Morgan Stanley has upgraded PTC Therapeutics (PTCT), while downgrading Immuneering (IMRX) and Amicus Therapeutics (FOLD).

Morgan Stanley kept Apple as its "Top Pick" for 2025 as the bank sees the tech giant's artificial intelligence (AI) product ...

The stock's fall snapped a two-day winning streak.

Sempra (NYSE:SRE) +1.5% in Friday's trading as Morgan Stanley upgrades to Overweight from Equal Weight with a $98 price ...

Morgan Stanley is close to an agreement to buy around €900 million ($940 million) in Spanish mortgages from Banco Santander ...

Could Google lose its dominance to artificial intelligence powered startups?  Will the new Department of Government ...

Nomura Holdings Inc. and Morgan Stanley are set to launch currency market-making services in India, according to people ...

Ellen Zentner, Morgan Stanley Wealth Management chief economic strategist, joins 'Money Movers' to discuss Zentner's thoughts ...

Morgan Stanley Direct Lending Fund offers a 10% dividend yield and a low-risk portfolio. Read why MSDL would be an appealing ...

Morgan Stanley Smith Barney will pay a $15 million penalty as part of a settlement with the Securities and Exchange ...

Morgan Stanley analyst Bob Huang notes that Progressive November results showed strong underwriting improvements, alleviating the fear of adverse selection, seasonal trends, and l ...

Morgan Stanley analyst Erik Woodring notes that Apple (AAPL) has outperformed the S&P 500 by 10 points over the last month and shares are ...